Abstract
Interleukin-6 (IL6) and Interleukin-8 (IL8) are cytokines related to general immune function, but within Sickle Cell Anemia (SCA) patients, their overproduction tends to cause auto-immune reactions. These vital cytokines engage in the pathophysiology of SCA, but the extent to which they are associated with the genetics of the disease requires further exploration. This research paper seeks to further the study of IL6 and IL8 in SCA patients as well as the possibilities to predict their presence in patients based on Haptoglobin alleles and various other hematological factors using artificial neural networks. This was done through a cross-sectional study of 60 sickle anemia patients and 74 healthy individuals who provided the basis for the data of this study. The deep learning model found a non-linear correlation between the Haptoglobin alleles and the production of IL6 and IL8, predicting their over presence in SCA patients with an accuracy of 90.9% and r-squared value of 0.88 based on the given inputs. The machine learning models built in this paper have the potential to accelerate the development of targeted treatments and diagnoses to those suffering from Sickle Cell Anemia and its specific immune complications.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of Universidade Federal de Sao Paulo (UNIFESP) gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
